학술논문
Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute.
Document Type
journal article
Author
Source
Journal of Clinical Oncology; 6/10/2022, Vol. 40 Issue 17, p1949-1957, 9p
Subject
Language
ISSN
0732183X